New cases tested for RR-/MDR-TB in Latvia
Latvia: New cases tested for RR-/MDR-TB was 80.0% in 2024. ▼ Falling
New cases tested for RR-/MDR-TB in Latvia, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for new cases tested for rr-/mdr-tb in Latvia is 80.0%, measured in 2024. That is the lowest value across all 16 years on record.
That represents a change of down 9.1% on the previous year and down 19.2% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Latvia peaked at 100.0% in 2005 and was at its lowest, 80.0%, in 2024.
That places Latvia 127th out of 192 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 16 years of available data.
New cases tested for RR-/MDR-TB in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 100.0% | — |
| 2006 | 100.0% | +0.0% |
| 2007 | 100.0% | +0.0% |
| 2008 | 100.0% | +0.0% |
| 2009 | 100.0% | +0.0% |
| 2010 | 96.0% | -4.0% |
| 2011 | 96.0% | +0.0% |
| 2012 | 97.0% | +1.0% |
| 2013 | 100.0% | +3.1% |
| 2014 | 99.0% | -1.0% |
| 2015 | 100.0% | +1.0% |
| 2016 | 100.0% | +0.0% |
| 2017 | 96.0% | -4.0% |
| 2021 | 83.0% | -13.5% |
| 2022 | 88.0% | +6.0% |
| 2024 | 80.0% | -9.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 100.0% | 5 |
| 2010s | 98.0% | 96.0% | 100.0% | 8 |
| 2020s | 83.7% | 80.0% | 88.0% | 3 |
Countries ranked near Latvia
- 126 Nigeria 81.0% compare
- 127 Iran, Islamic Republic of 80.0% compare
- 127 Malawi 80.0% compare
- 130 Philippines 79.0% compare
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Heat deaths vs projected death rates 1,593 (2090)
- Un projection of annual infant deaths 4 (2100)
- Population ages 15-64, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.3094 units per person (2025)
- Population ages 15-64, total, annual growth rate -1.35 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.6262 units per person (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Latvia?
- New cases tested for rr-/mdr-tb in Latvia was 80.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Latvia?
- The highest recorded value was 100.0% in 2005.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Latvia?
- The lowest recorded value was 80.0% in 2024.
- How does Latvia rank for new cases tested for rr-/mdr-tb?
- Latvia ranks 127th out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Latvia?
- Over the last ten years it is down 19.2%. The long-run trend across the full record is falling.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).